Provided by Tiger Fintech (Singapore) Pte. Ltd.

ADMA Biologics

22.33
+0.60002.76%
Post-market: 22.03-0.3000-1.34%16:36 EDT
Volume:2.17M
Turnover:48.11M
Market Cap:5.31B
PE:27.57
High:22.37
Open:21.82
Low:21.80
Close:21.73
Loading ...
May 11, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 25, 2022

Major Issues Report

8-K - Current report
Mar 24, 2022

Major Issues Report

8-K - Current report
Mar 24, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 09, 2022

Major Issues Report

8-K - Current report
Mar 07, 2022

Major Issues Report

8-K - Current report
Mar 07, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 15, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 04, 2022

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Jan 19, 2022

Major Issues Report

8-K - Current report
Jan 18, 2022

Major Issues Report

8-K - Current report
Dec 30, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 21, 2021

Major Issues Report

8-K - Current report
Oct 26, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Oct 26, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Oct 26, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Oct 26, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities